Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

FACTOR Abstract Submission

MIB Agents

MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to making it better for our community of patients, families, medical professionals, researchers, and industry partners through programs, education, and research.

ABOUT FACTOR 2025 Started in 2017, the annual MIB Agents FACTOR conference brings together key stakeholders in the osteosarcoma community, including clinicians, researchers, industry, patients, families, patient advocates, and funders to Make It Better for those battling this disease. FACTOR stands for Funding, Awareness, Collaboration, Trials, Osteosarcoma, and Research. In bringing the osteosarcoma community together, the goal is to drive collaboration on advancing treatments and improving outcomes for patients with osteosarcoma.

● Foster Collaboration: Facilitate connections among researchers, clinicians, surgeons, and patient families to enhance multidisciplinary collaboration in osteosarcoma research and treatment.

● Improve Patient Outcomes: Focus on strategies to enhance treatment effectiveness, reduce side effects, and improve the quality of life for patients living with osteosarcoma.

● Promote Research: Highlight cutting-edge research in osteosarcoma, with a focus on developing novel therapies, understanding disease mechanisms, and improving patient outcomes.

● Educate and Inform: Share the latest advances in osteosarcoma treatment and research with medical professionals, patients, and advocates to keep the community informed and engaged.

● Expand Clinical Trials: Encourage participation in and development of clinical trials to explore new treatments, improve existing therapies, and gather critical data for future innovations.

● Drive Funding and Awareness: Raise awareness about osteosarcoma and emphasize the need for increased funding to support ongoing research and clinical trials.

● Strengthen the Community: Build a stronger support network for patient families and survivors by providing a platform for sharing experiences, challenges, and successes.

FACTOR 2025 will be held in person June 26-28, 2025 at The Grand America Hotel in Salt Lake City, UT. Registration for FACTOR 2025 will open in February 2025 on the MIB Agents website. See past FACTOR conference agendas and speakers

SUBMISSION AND SELECTION PROCESS Authors may submit abstracts for presentation at FACTOR 2025 on Proposal Central, beginning October 7, 2024. Abstracts can be created, modified, and submitted until the final date on January 10, 2025. Abstracts will be considered for oral presentation or poster presentation at FACTOR 2025.

Specialties

Cancer

Orthopedics

Oncology

Pediatrics

Eligibility Requirements

● Individuals may submit up to 2 abstracts as the first author.

● Presenting authors must be registered FACTOR 2025 participants. Submitting an abstract for presentation at FACTOR 2025 does not constitute registration for the meeting.

● If selected for oral presentation at FACTOR 2025, authors will receive a promotional code to use during conference registration. This promotional code will cover conference registration fees.

● If their institutions will not cover accommodation costs, oral and poster presenters may apply for a Family Fund FACTOR Travel Award.

● An abstract can be submitted if it was/will be presented at a scientific meeting in the past year. If it was presented prior to 2024, then it cannot be submitted unless there is significant new data.

Sponsor Details

Sponsor Institute/Organizations: MIB Agents

Address: P.O. Box 858, Barnard, VT 05031 518.524.3890 hello@MIBagents.org

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity